Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Long-term renal function in children after liver transplantation.

Kivelä JM, Räisänen-Sokolowski A, Pakarinen MP, Mäkisalo H, Jalanko H, Holmberg C, Lauronen J.

Transplantation. 2011 Jan 15;91(1):115-20.

PMID:
21452415
2.

Immunosuppression in liver transplant recipients with renal impairment.

Duvoux C, Pageaux GP.

J Hepatol. 2011 May;54(5):1041-54. doi: 10.1016/j.jhep.2010.12.001. Epub 2010 Dec 9. Review. No abstract available.

3.

Long-term maintenance therapy with calcineurin inhibitors: an update.

Campistol JM.

Transplant Proc. 2010 Nov;42(9 Suppl):S21-4. doi: 10.1016/j.transproceed.2010.09.015. Review.

PMID:
21095445
4.

Deciphering calcineurin inhibitor nephrotoxicity: a pharmacological approach.

Pallet N, Legendre C.

Pharmacogenomics. 2010 Oct;11(10):1491-501. doi: 10.2217/pgs.10.137. Review.

PMID:
21047207
5.

Quantitative analyses of kidney injury molecule-1 messenger RNA in kidney transplant recipients with graft dysfunction.

Nogare AL, Joelsons G, Pedroso JA, Veronese FJ, Gonçalves LF, Manfro RC.

Transplant Proc. 2010 Mar;42(2):473-4. doi: 10.1016/j.transproceed.2010.01.042.

PMID:
20304168
6.

Transcriptome changes of chronic tubulointerstitial damage in early kidney transplantation.

Vitalone MJ, O'Connell PJ, Wavamunno M, Fung CL, Chapman JR, Nankivell BJ.

Transplantation. 2010 Mar 15;89(5):537-47. doi: 10.1097/TP.0b013e3181ca7389.

PMID:
20147884
7.

Calcineurin inhibitor nephrotoxicity.

Naesens M, Kuypers DR, Sarwal M.

Clin J Am Soc Nephrol. 2009 Feb;4(2):481-508. doi: 10.2215/CJN.04800908. Review.

8.

Intrarenal activation of renin angiotensin system in the development of cyclosporine A induced chronic nephrotoxicity.

Shang MH, Yuan WJ, Zhang SJ, Fan Y, Zhang Z.

Chin Med J (Engl). 2008 Jun 5;121(11):983-8.

PMID:
18706245
9.

Urinary epidermal growth factor and interleukin-6 levels in patients with painful bladder syndrome/interstitial cystitis treated with cyclosporine or pentosan polysulfate sodium.

Sairanen J, Hotakainen K, Tammela TL, Stenman UH, Ruutu M.

Urology. 2008 Apr;71(4):630-3. doi: 10.1016/j.urology.2007.11.055.

PMID:
18387391
10.

Validation of putative genomic biomarkers of nephrotoxicity in rats.

Wang EJ, Snyder RD, Fielden MR, Smith RJ, Gu YZ.

Toxicology. 2008 Apr 18;246(2-3):91-100. doi: 10.1016/j.tox.2007.12.031. Epub 2008 Jan 16.

PMID:
18289764
11.

KIM-1 expression in kidney allograft biopsies: Improving the gold standard.

Abulezz S.

Kidney Int. 2008 Mar;73(5):522-3. doi: 10.1038/sj.ki.5002772.

12.

Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1.

Richardson C, Rafiqi FH, Karlsson HK, Moleleki N, Vandewalle A, Campbell DG, Morrice NA, Alessi DR.

J Cell Sci. 2008 Mar 1;121(Pt 5):675-84. doi: 10.1242/jcs.025312. Epub 2008 Feb 12.

13.

WNK kinases and renal sodium transport in health and disease: an integrated view.

McCormick JA, Yang CL, Ellison DH.

Hypertension. 2008 Mar;51(3):588-96. doi: 10.1161/HYPERTENSIONAHA.107.103788. Epub 2008 Jan 22. Review. No abstract available.

14.

Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury.

Zhang PL, Rothblum LI, Han WK, Blasick TM, Potdar S, Bonventre JV.

Kidney Int. 2008 Mar;73(5):608-14. Epub 2007 Dec 26.

15.
16.

The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.

Kobori H, Nangaku M, Navar LG, Nishiyama A.

Pharmacol Rev. 2007 Sep;59(3):251-87. Review.

17.

Downregulation of renal sodium transporters and tonicity-responsive enhancer binding protein by long-term treatment with cyclosporin A.

Lim SW, Ahn KO, Sheen MR, Jeon US, Kim J, Yang CW, Kwon HM.

J Am Soc Nephrol. 2007 Feb;18(2):421-9. Epub 2007 Jan 3.

18.

Protein biomarkers associated with acute renal failure and chronic kidney disease.

Perco P, Pleban C, Kainz A, Lukas A, Mayer G, Mayer B, Oberbauer R.

Eur J Clin Invest. 2006 Nov;36(11):753-63. Review.

PMID:
17032342
19.

Sodium transporters in the distal nephron and disease implications.

Ecelbarger CA, Tiwari S.

Curr Hypertens Rep. 2006 May;8(2):158-65. Review.

PMID:
16672150
20.

Immunosuppression: evolution in practice and trends, 1994-2004.

Meier-Kriesche HU, Li S, Gruessner RW, Fung JJ, Bustami RT, Barr ML, Leichtman AB.

Am J Transplant. 2006;6(5 Pt 2):1111-31.

Supplemental Content

Support Center